Events
WCLC 2022: NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients with resectable non-small cell lung cancer
- WCLC 2022: Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy
- WCLC 2022: Budget impact analysis demonstrates NELSON screening model would save more than 18,000 premature lung cancer deaths
- WCLC 2022: Chinese researchers develop lung cancer risk prediction nomogram for female non-smokers
Without additional investment 11 million children are expected to die from cancer between now and 2050
Improving care for children with cancer worldwide will bring a triple return on investment and prevent millions of needless deaths,…










